Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
A recent review discussed the current and possible future applications of infrared thermal imaging (IRT) to diagnose Raynaud’s phenomenon. The authors ... Read more
Cytori Therapeutics will expand the development of its ECCS-50 scleroderma treatment to include secondary Raynaud’s phenomenon (RP), under the brand Habeo ... Read more
Corbus Pharmaceuticals is starting a one-year, open-label extension study for the ongoing Phase 2 clinical trial evaluating the effect of Resunab in ... Read more
Cytori Therapeutics will present data from its Phase 3 STAR clinical trial (NCT02396238) assessing the safety and effectiveness of adipose-derived regenerative cells (ADRCs) ... Read more
Therapeutic plasma exchange, the removal of harmful components from plasma in blood, may be an effective therapy for patients with systemic ... Read more
Blood vessel anomalies seen in people with Raynaud’s syndrome (RS) are associated with abnormal levels of molecular factors that influence blood vessel ... Read more
The use of epinephrine in anesthesia during finger surgery in patients with Raynaud’s disease may significantly exacerbate the condition and can even ... Read more
A device called “magic gloves” created by engineering students from Virginia Commonwealth University helps people with Raynaud’s disease regulate the temperature in ... Read more
